gastroesophageal reflux disease in children with episodes of recurrent wheeze

gastroesophageal reflux disease in children with episodes of recurrent wheeze - gastroesophageal reflux disease in children with episodes of recurrent wheeze

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005203

Enrollment

Registered

2011-03-08

Start date

2009-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wheezing infant

Interventions

pH monitoring is undertaken in all subjects, and all subjects prescribe for famotidine therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children with episodes of recurrent wheeze evenif they use inhaled corticosteroid

Exclusion criteria

Exclusion criteria: children with pulmonary disease, neurological disease and other basic disorders.

Design outcomes

Primary

Measure	Time frame
diagnosis of gastroesophageal reflux disease based on efficacy of famotidine therapy	—

Secondary

Measure	Time frame
baseline of pH monitoring	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026